I remember (I think) reading here, before I became a ‘user’, that age-health related gains made by taking Rapa… stayed with you if you ever stopped taking it. So if I regressed my body-age through Rapa by 5 years…it would take about 5 years for that benefit to wear off…or I would start aging normally from that age regressed age.
Is this memory a good one?
What is the latest information on this ?
This is perhaps one of the key mechanistic questions. I take the view that additional autophagy (mitophagy) that improves mitochondrial efficiency is a discrete process that is enhanced with rapamycin. Hence each cycle of efficiency improvements lasts until the normal gradual deterioration of efficiency that occurs with metabolism has erased it.
There is evidence of interventions at an earlier stage having effects at later points.
However, some people disagree as to what the mechanism is.
The “carryover affect” theory was what encouraged me to take it in the first place. Inspired by: Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice | eLife
Summary;
The Method: Researchers took middle-aged mice (20 months old, roughly equivalent to a 60-to-65-year-old human) and gave them rapamycin for just 3 months (90 days). Treatment was then permanently stopped, and the mice were followed for the rest of their lives.
The Results: Despite stopping the drug, the treated mice experienced a 60% increase in remaining life expectancy compared to the control group.
Healthspan Improvements: Long after stopping the drug, the mice showed sustained improvements in muscle strength, motor coordination, and a remodeled gut microbiome.
The reasoning is debated but could be…
Autophagy Reset: Rapamycin triggers a massive cellular cleanup process (autophagy). Clearing out decades of cellular “garbage” (damaged proteins and organelles) lowers systemic inflammation long after the drug leaves the system.
Microbiome Remodeling: The 3-month trial showed a persistent shift toward a younger, healthier gut microbiome (specifically an increase in segmented filamentous bacteria), which provides long-lasting metabolic and immune support.
Stem Cell Rejuvenation: Transient mTOR inhibition helps reset exhausted adult stem cell niches, allowing tissues to maintain better regenerative capacity even after normal aging rates resume.